Education
About Us
Working with TipRanks
Follow Us
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.59M | $ 3.31M | $ 9.01M | $ 1.24M | $ 466.79K |
| Gross Profit | $ -6.88M | $ -7.11M | $ 5.32M | $ -1.92M | $ -18.41M |
| Operating Income | $ -11.12M | $ -14.58M | $ -19.79M | $ -39.48M | $ -28.89M |
| EBITDA | $ -4.53M | $ -11.27M | $ -19.79M | $ -36.31M | $ -27.63M |
| Net Income | $ -10.73M | $ -8.24M | $ -29.93M | $ -41.88M | $ -28.71M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 19.19M | $ 15.11M | $ 11.78M | $ 42.35M | $ 21.35M |
| Total Assets | $ 22.02M | $ 17.13M | $ 34.42M | $ 68.14M | $ 45.61M |
| Total Debt | $ 0.00 | $ 0.00 | $ 7.62M | $ 11.87M | $ 12.26M |
| Net Debt | $ -19.19M | $ -15.11M | $ -4.17M | $ -30.48M | $ -9.10M |
| Total Liabilities | $ 3.46M | $ 3.07M | $ 14.82M | $ 24.15M | $ 18.27M |
| Stockholders' Equity | $ 18.56T | $ 14.05M | $ 19.60M | $ 43.99M | $ 27.34M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.91M | $ -16.44M | $ -31.92M | $ -30.41M | $ -29.29M |
| Operating Cash Flow | $ -10.91M | $ -16.44M | $ -26.97M | $ -27.28M | $ -18.86M |
| Investing Cash Flow | $ 0.00 | $ 18.66M | $ -4.95M | $ -3.13M | $ -10.43M |
| Financing Cash Flow | $ 14.99M | $ 1.11M | $ 202.13K | $ 52.56M | $ 6.74M |
Marker Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.